<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02146404</url>
  </required_header>
  <id_info>
    <org_study_id>1H_lac_acc</org_study_id>
    <nct_id>NCT02146404</nct_id>
  </id_info>
  <brief_title>The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood Flow</brief_title>
  <official_title>The Effect of Insulin-induced Hypoglycemia on Brain Lactate Accumulation and Regional Cerebral Blood Flow in Patients With Type 1 Diabetes Mellitus With and Without Hypoglycemia Unawareness and Non-diabetic Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Diabetes Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Foundation for the Study of Diabetes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iatrogenic hypoglycemia is the most frequent acute complication of insulin therapy in people
      with type 1 diabetes (T1DM). Recurrent hypoglycemic events initiate a process of habituation,
      characterized by suppression of hypoglycemic symptoms and lead to hypoglycemia unawareness,
      which in itself defines a particularly high risk of severe hypoglycemia. Recent evidence
      suggest a pivotal role for increased brain lactate transport capacity in the pathogenesis of
      hypoglycemia unawareness. However, there is uncertainty about the magnitude of this effect
      and whether such excess brain lactate is oxidizes as a glucose-sparing alternative energy
      source or acts as a metabolic regulator controlling brain glucose metabolism, oxygen
      consumption and cerebral blood flow.

      Objective: The primary objective of this study is to investigate the effect of hypoglycemia
      on brain lactate accumulation and regional cerebral blood perfusion in humans. The secondary
      objective is to assess whether this effect is a related to hypoglycemia unawareness or a
      consequence of T1DM per se.

      Hypothesis: The investigators hypothesize that hypoglycemia stimulates lactate transport over
      the blood-brain barrier leading to cerebral lactate accumulation and that this lactate
      accumulation is a function of prior hypoglycemic exposure frequency contributing to clinical
      hypoglycemia unawareness. Furthermore, the investigators expect that this effect of
      hypoglycemia on brain lactate accumulation is related to changes in cerebral blood flow
      (CBF).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain lactate concentration</measure>
    <time_frame>during stable euglycemia and hypoglyemia</time_frame>
    <description>Concentration brain lactate measured with 1H-MRS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma lactate levels</measure>
    <time_frame>during stable euglycemia and hypoglyemia</time_frame>
    <description>Concentration arterial plasma lactate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormone response</measure>
    <time_frame>during stable euglycemia and hypoglyemia</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Hypoglycemia Unawareness</condition>
  <arm_group>
    <arm_group_label>Euglycemia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Plasma glucose levels will be clamped at a constant value of ~5.0 mmol/l</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypoglycemia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plasma glucose levels will be clamped at a stable value of ~3.0 mmol/l</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypoglycemia</intervention_name>
    <description>Blood glucose levels will be kept at ~3.0 mmol/l</description>
    <arm_group_label>Hypoglycemia</arm_group_label>
    <other_name>Low blood glucose levels</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>euglycemia</intervention_name>
    <description>Blood glucose levels will be kept at ~5.0 mmol/l</description>
    <arm_group_label>Euglycemia</arm_group_label>
    <other_name>Normal blood glucose levels</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria for healthy subjects

          -  Age: 18-50 years

          -  Body-Mass Index: 18-30 kg/m2

          -  Blood pressure: &lt;160/90 mmHg

        Inclusion criteria T1DM patients with normal hypoglycemic awareness

          -  Diabetes duration ≥ 1 year

          -  Age: 18-50 years

          -  Body-Mass Index: 18-30 kg/m2

          -  HbA1c: 42-75 mmol/mol (6-9%)

          -  Outcome Clarke questionnaire: 0-1

          -  Blood pressure: &lt;160/90 mmHg

        Inclusion criteria T1DM patients with hypoglycemia unawareness

          -  Diabetes duration ≥ 1 year

          -  Age: 18-50 years

          -  Body-Mass Index: 18-30 kg/m2

          -  HbA1c: 42-75 mmol/mol (6-9%)

          -  Outcome Clarke questionnaire: &gt;3

          -  Blood pressure: &lt;160/90 mmHg

        Exclusion criteria for healthy subjects

          -  Inability to provide informed consent

          -  Presence of any medical condition that might interfere with the study protocol, such
             as brain injuries, epilepsy, a major cardiovascular disease event or anxiety disorders

          -  Use of any medication, except for oral contraceptives

          -  MR(I) contraindications (pregnancy, severe claustrophobia, metal parts in body)

        Exclusion criteria for all T1DM patients

          -  Inability to provide informed consent

          -  Presence of any other medical condition that might interfere with the study protocol,
             such as brain injuries, epilepsy, a major cardiovascular disease event, anxiety
             disorders, or complications of T1DM (including neuropathy and retinopathy)

          -  Use of any other medication than insulin, except for oral contraceptives or stable
             thyroxine supplementation therapy

          -  MR(I) contraindications (pregnancy, severe claustrophobia, metal parts in body)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bastiaan de Galan, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud umc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud umc</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>van de Ven KC, van der Graaf M, Tack CJ, Klomp DW, Heerschap A, de Galan BE. Optimized [1-(13)C]glucose infusion protocol for 13C magnetic resonance spectroscopy at 3T of human brain glucose metabolism under euglycemic and hypoglycemic conditions. J Neurosci Methods. 2010 Jan 30;186(1):68-71. doi: 10.1016/j.jneumeth.2009.10.025. Epub 2009 Nov 11.</citation>
    <PMID>19913052</PMID>
  </reference>
  <reference>
    <citation>van de Ven KC, de Galan BE, van der Graaf M, Shestov AA, Henry PG, Tack CJ, Heerschap A. Effect of acute hypoglycemia on human cerebral glucose metabolism measured by ¹³C magnetic resonance spectroscopy. Diabetes. 2011 May;60(5):1467-73. doi: 10.2337/db10-1592. Epub 2011 Apr 4.</citation>
    <PMID>21464446</PMID>
  </reference>
  <reference>
    <citation>van de Ven KC, van der Graaf M, Tack CJ, Heerschap A, de Galan BE. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes. 2012 Aug;61(8):1974-7. doi: 10.2337/db11-1778. Epub 2012 Jun 11.</citation>
    <PMID>22688331</PMID>
  </reference>
  <reference>
    <citation>van de Ven KC, Tack CJ, Heerschap A, van der Graaf M, de Galan BE. Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia. J Clin Invest. 2013 Feb;123(2):623-9. doi: 10.1172/JCI62742. Epub 2013 Jan 9.</citation>
    <PMID>23298837</PMID>
  </reference>
  <reference>
    <citation>Herzog RI, Jiang L, Herman P, Zhao C, Sanganahalli BG, Mason GF, Hyder F, Rothman DL, Sherwin RS, Behar KL. Lactate preserves neuronal metabolism and function following antecedent recurrent hypoglycemia. J Clin Invest. 2013 May;123(5):1988-98. doi: 10.1172/JCI65105. Epub 2013 Apr 1.</citation>
    <PMID>23543056</PMID>
  </reference>
  <reference>
    <citation>De Feyter HM, Mason GF, Shulman GI, Rothman DL, Petersen KF. Increased brain lactate concentrations without increased lactate oxidation during hypoglycemia in type 1 diabetic individuals. Diabetes. 2013 Sep;62(9):3075-80. doi: 10.2337/db13-0313. Epub 2013 May 28.</citation>
    <PMID>23715622</PMID>
  </reference>
  <reference>
    <citation>Bergersen LH, Gjedde A. Is lactate a volume transmitter of metabolic states of the brain? Front Neuroenergetics. 2012 Mar 19;4:5. doi: 10.3389/fnene.2012.00005. eCollection 2012.</citation>
    <PMID>22457647</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2014</study_first_submitted>
  <study_first_submitted_qc>May 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2014</study_first_posted>
  <last_update_submitted>November 9, 2015</last_update_submitted>
  <last_update_submitted_qc>November 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 1 Diabetes Mellitus</keyword>
  <keyword>Hypoglycemia unawareness</keyword>
  <keyword>1H MRS</keyword>
  <keyword>Lactate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Unconsciousness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

